These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome. Seo Y; Jeong EG; Kim ES Endocrine; 2015 Nov; 50(2):519-21. PubMed ID: 26298265 [No Abstract] [Full Text] [Related]
8. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Malik KJ; Wakelin K; Dean S; Cove DH; Wood PJ Ann Clin Biochem; 1996 May; 33 ( Pt 3)():187-9. PubMed ID: 8791979 [TBL] [Abstract][Full Text] [Related]
9. Progestogens and Cushing's syndrome. Harte C; Henry MT; Murphy KD; Mitchell TH Ir J Med Sci; 1995; 164(4):274-5. PubMed ID: 8522428 [TBL] [Abstract][Full Text] [Related]
10. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency. Krueger RB; Hembree W; Hill M Sex Abuse; 2006 Apr; 18(2):227-8. PubMed ID: 16868842 [TBL] [Abstract][Full Text] [Related]
11. Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer. Ngelangel CA; Jimenez MV; Villalon AH; Agustin BM Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):634-7. PubMed ID: 2940689 [TBL] [Abstract][Full Text] [Related]
13. [Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system]. Schenk H; Fereberger W MMW Munch Med Wochenschr; 1983 Oct; 125(40):875-6. PubMed ID: 6226871 [No Abstract] [Full Text] [Related]
15. Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients. Pannuti F; Longhi A; Martoni A; Piana E; Baroni M Chemioterapia; 1987 Dec; 6(6):396-8. PubMed ID: 2963702 [TBL] [Abstract][Full Text] [Related]
19. Quality of life after cytotoxic chemotherapy: discussion paper. Priestman TJ J R Soc Med; 1984 Jun; 77(6):492-5. PubMed ID: 6234393 [No Abstract] [Full Text] [Related]
20. A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria. Kong WY; Leedman P; Irish A Intern Med J; 2014 Sep; 44(9):932-4. PubMed ID: 25201428 [No Abstract] [Full Text] [Related] [Next] [New Search]